Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Authors: Markus Joerger, Joachim von Pawel, Stefanie Kraff, Jürgen R. Fischer, Wilfried Eberhardt, Thomas Gauler, Lothar Mueller, Niels Reinmuth, Martin Reck, Martin Kimmich, F. Mayer, Hans‐Georg Kopp, Dirk Behringer, Yon‐Dschun Ko, Ralf A. Hilger, Max Roessler, Charlotte Kloft, Andrea Henrich, Berta Moritz, Michael Craig Miller, Salvatore J. Salamone, Ulrich Jaehde - Annals of Oncology 2016 cited by 89